发明名称 INHIBITORS OF ADAMTS4 OR ADAMTS5 FOR USE IN PREVENTING OR TREATING CARDIAC REMODELING AND CHRONIC HEART FAILURE
摘要 The present invention provides an inhibitor of an ADAMTS proteoglycanase for use in treating or preventing cardiac remodeling or for use in treating or preventing heart failure in a subject. In particular, the present invention provides an inhibitor of ADAMTS4 or ADAMTS5 for use in treating or preventing cardiac remodeling or chronic heart failure in a subject with cardiac remodeling or with chronic heart failure, or with a condition that may lead to cardiac remodeling and/or chronic heart failure. Also provided is a method of treating or preventing cardiac remodeling or treating or preventing heart failure which method comprises administering to a subject in need thereof a therapeutically effective amount of an inhibitor of an ADAMTS proteoglycanase. Also provided is the use of an inhibitor of an ADAMTS proteoglycanase in the manufacture of a medicament for treating or preventing cardiac remodeling or treating or preventing heart failure.
申请公布号 US2016158271(A1) 申请公布日期 2016.06.09
申请号 US201414903624 申请日期 2014.07.09
申请人 UNIVERSITETET I OSLO 发明人 VISTNES Maria;CHRISTENSEN Geir;ARONSEN Magnus;LUNDE Ida Gjervold;SJAASTAD Ivar;CARLSON Cathrine Rein
分类号 A61K31/737;A61K31/453 主分类号 A61K31/737
代理机构 代理人
主权项 1. A method for treating or preventing cardiac remodeling or chronic heart failure in a subject comprising administering a therapeutically effective amount of an inhibitor of ADAMTS4 or ADAMTS5 to a subject having cardiac remodeling or chronic heart failure, or a subject having a condition that may lead to cardiac remodeling and/or chronic heart failure.
地址 Oslo NO